$GATO
Gatos Silver, Inc.

2024 Q4 Form 10-Q Financial Statement

#000162828024046787 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.58M
YoY Change 41.16%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $21.00M
YoY Change 1457.57%
Pretax Income $10.41M
YoY Change 216.7%
Income Tax $529.0K
% Of Pretax Income 5.08%
Net Earnings $9.884M
YoY Change 200.61%
Net Earnings / Revenue
Basic Earnings Per Share $0.14
Diluted Earnings Per Share $0.14
COMMON SHARES
Basic Shares Outstanding 69.38M shares 69.34M shares
Diluted Shares Outstanding 71.61M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $116.7M
Short-Term Investments
Other Short-Term Assets $1.215M
YoY Change -92.38%
Inventory
Prepaid Expenses $558.0K
Receivables
Other Receivables
Total Short-Term Assets $118.2M
YoY Change 134.14%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $285.5M
YoY Change -13.16%
Other Assets $348.0K
YoY Change 728.57%
Total Long-Term Assets $286.0M
YoY Change -13.0%
TOTAL ASSETS
Total Short-Term Assets $118.2M
Total Long-Term Assets $286.0M
Total Assets $404.3M
YoY Change 6.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.686M
YoY Change 149.86%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$164.3M
YoY Change -17.1%
Common Stock $117.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $391.9M
YoY Change
Total Liabilities & Shareholders Equity $404.3M
YoY Change 6.6%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $9.884M
YoY Change 200.61%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Central Index Key
EntityCentralIndexKey
0001517006
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39649
dei Entity Registrant Name
EntityRegistrantName
GATOS SILVER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
dei Entity Address Address Line1
EntityAddressAddressLine1
925 W Georgia Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 910
dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
dei Entity Address Country
EntityAddressCountry
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3L2
dei City Area Code
CityAreaCode
(604)
dei Trading Symbol
TradingSymbol
GATO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69376647 shares
CY2024Q3 us-gaap Other Receivables
OtherReceivables
292000 usd
CY2023Q4 us-gaap Other Receivables
OtherReceivables
560000 usd
CY2024Q3 us-gaap Exploration Expense
ExplorationExpense
144000 usd
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
0 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10435000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7494000 usd
CY2024Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
4000 usd
CY2023Q3 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
3000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
10583000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
7497000 usd
us-gaap Operating Expenses
OperatingExpenses
19257000 usd
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
116732000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
55484000 usd
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
222000 usd
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
266000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
348000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38000 usd
CY2024Q3 us-gaap Assets
Assets
404263000 usd
CY2023Q4 us-gaap Assets
Assets
400904000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
12226000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
33357000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
187000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69352645 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69181047 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
117000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
117000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
556050000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
553319000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-164317000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-185889000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
391850000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
367547000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
404263000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
400904000 usd
dei Local Phone Number
LocalPhoneNumber
424-0984
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
us-gaap Exploration Expense
ExplorationExpense
219000 usd
us-gaap Exploration Expense
ExplorationExpense
26000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25270000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19157000 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
11000 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
74000 usd
us-gaap Operating Expenses
OperatingExpenses
25500000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39985000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
332000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
679000 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1322000 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
389000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
3206000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
676000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1503000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1291000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4582000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3868000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
20996000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10785000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
47773000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19787000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10413000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3288000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
22273000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
530000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
529000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
701000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3288000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3288000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
530000 usd
us-gaap Net Income Loss
NetIncomeLoss
530000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69343979 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69247280 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71613178 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69524838 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71110386 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69381222 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
367547000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3593000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1215000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
22642000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
118239000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
78686000 usd
CY2024Q3 us-gaap Equity Method Investments
EquityMethodInvestments
285454000 usd
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
321914000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
18171000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9437000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15922000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9884000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
9884000 usd
us-gaap Net Income Loss
NetIncomeLoss
21572000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21572000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
2532000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
371768000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1615000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-1778000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
110000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
9156000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
380878000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
56000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
9884000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
391850000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
348482000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
783000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
835000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
350100000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
416000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
346923000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2122000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3288000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
352887000 usd
us-gaap Net Income Loss
NetIncomeLoss
21572000 usd
us-gaap Net Income Loss
NetIncomeLoss
530000 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
11000 usd
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
74000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4319000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3327000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39985000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15922000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-94000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-837000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
76445000 usd
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
35000000 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-268000 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-678000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-23007000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-21454000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-936000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
61171000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25465000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
166000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
89000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
9000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
77000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
61248000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16465000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55484000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17004000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
116732000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33469000 usd
us-gaap Interest Paid Net
InterestPaidNet
16000 usd
us-gaap Interest Paid Net
InterestPaidNet
417000 usd
gato Interest Earned Excluding Capitalized Interest Operating Activities
InterestEarnedExcludingCapitalizedInterestOperatingActivities
3206000 usd
gato Interest Earned Excluding Capitalized Interest Operating Activities
InterestEarnedExcludingCapitalizedInterestOperatingActivities
690000 usd
CY2024Q3 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
647000 usd
CY2023Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
691000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
558000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1914000 usd
CY2024Q3 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
0 usd
CY2023Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
20000000 usd
CY2024Q3 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
10000 usd
CY2023Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
37000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1215000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
22642000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
319000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
132000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
187000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2686000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2713000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6379000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3031000 usd
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2481000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3215000 usd
CY2024Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
24000000 usd
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
548000 usd
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
387000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
132000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
11000 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
12226000 usd
CY2023Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
33357000 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
1024000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
2122000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4319000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3327000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
647753 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.88
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1132520 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1132520 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.93
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.93
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
52475 shares
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2716000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0456
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0386
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5842
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5800
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
9884000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
3288000 usd
us-gaap Net Income Loss
NetIncomeLoss
21572000 usd
us-gaap Net Income Loss
NetIncomeLoss
530000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69343979 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69247280 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71613178 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69524838 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71110386 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69381222 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.14
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.14
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q3 us-gaap Exploration Expense
ExplorationExpense
144000 usd
CY2023Q3 us-gaap Exploration Expense
ExplorationExpense
0 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10435000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7494000 usd
CY2024Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
4000 usd
CY2023Q3 us-gaap Adjustment For Amortization
AdjustmentForAmortization
3000 usd
CY2024Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
18171000 usd
CY2023Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
9437000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
332000 usd
CY2024Q3 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
1322000 usd
CY2023Q3 us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
389000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1503000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1291000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
529000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Assets
Assets
404263000 usd
CY2023Q3 us-gaap Assets
Assets
379250000 usd
us-gaap Exploration Expense
ExplorationExpense
219000 usd
us-gaap Exploration Expense
ExplorationExpense
26000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25270000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19157000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
11000 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
74000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
39985000 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
15922000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
0 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
679000 usd
us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
3206000 usd
us-gaap Interest Income Interest Earning Asset
InterestIncomeInterestEarningAsset
676000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4582000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3868000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
701000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q3 us-gaap Assets
Assets
404263000 usd
CY2023Q3 us-gaap Assets
Assets
379250000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
gato-20240930_lab.xml Edgar Link unprocessable
0001628280-24-046787-index-headers.html Edgar Link pending
0001628280-24-046787-index.html Edgar Link pending
0001628280-24-046787.txt Edgar Link pending
0001628280-24-046787-xbrl.zip Edgar Link pending
ceocert10-q2024q3.htm Edgar Link pending
cfocert10-q2024q3.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gato-20240930.htm Edgar Link pending
gato-20240930.xsd Edgar Link pending
gato-20240930_g1.jpg Edgar Link pending
gato-20240930_def.xml Edgar Link unprocessable
gato-20240930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gato-20240930_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
soxcert10-q2024q3.htm Edgar Link pending
gato-20240930_pre.xml Edgar Link unprocessable